CLIN COLORECTAL CANC 润色咨询

Clinical Colorectal Cancer

出版年份:2001 年文章数:743 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:2.9% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1100040, encodeId=1efd110004067, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218184, encodeId=49dd1218184bc, content=投个案的时候需要上传Clinical Practice Points,有没有大佬知道这是什么意思呀?需要怎么准备呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca065431027, createdName=ms4000001550793649, createdTime=Mon May 09 13:52:57 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100039, encodeId=3f001100039a3, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548146, encodeId=abba54814655, content=楼下说的确实太慢了,现在如何,中间没有催过吗? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a33e1700270, createdName=dapengshiwo, createdTime=Wed Oct 11 20:42:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547302, encodeId=34d754e30284, content=投稿两个月了,还是with editor 不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8031642220, createdName=黄倩倩, createdTime=Sun Sep 17 20:56:00 CST 2017, time=2017-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522551, encodeId=87205225517e, content=投稿两个月,状态还是“with editor”,这是什么意思?!肯本没送审,等着毕业呀,好歹给个消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f119101875, createdName=Blank, createdTime=Wed May 18 09:53:00 CST 2016, time=2016-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504526, encodeId=26575045264e, content=总体来说,形式是比较看好的,今年快到3分左右,比去年高了不少,明年应该能达到3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiming, createdTime=Wed Jul 30 12:55:00 CST 2014, time=2014-07-30, status=1, ipAttribution=)]
    2021-12-28 小动量

    如何判断两种药物之间是协同作用还是相加作用?

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1100040, encodeId=1efd110004067, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218184, encodeId=49dd1218184bc, content=投个案的时候需要上传Clinical Practice Points,有没有大佬知道这是什么意思呀?需要怎么准备呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca065431027, createdName=ms4000001550793649, createdTime=Mon May 09 13:52:57 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100039, encodeId=3f001100039a3, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548146, encodeId=abba54814655, content=楼下说的确实太慢了,现在如何,中间没有催过吗? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a33e1700270, createdName=dapengshiwo, createdTime=Wed Oct 11 20:42:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547302, encodeId=34d754e30284, content=投稿两个月了,还是with editor 不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8031642220, createdName=黄倩倩, createdTime=Sun Sep 17 20:56:00 CST 2017, time=2017-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522551, encodeId=87205225517e, content=投稿两个月,状态还是“with editor”,这是什么意思?!肯本没送审,等着毕业呀,好歹给个消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f119101875, createdName=Blank, createdTime=Wed May 18 09:53:00 CST 2016, time=2016-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504526, encodeId=26575045264e, content=总体来说,形式是比较看好的,今年快到3分左右,比去年高了不少,明年应该能达到3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiming, createdTime=Wed Jul 30 12:55:00 CST 2014, time=2014-07-30, status=1, ipAttribution=)]
    2022-05-09 ms4000001550793649

    投个案的时候需要上传Clinical Practice Points,有没有大佬知道这是什么意思呀?需要怎么准备呢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1100040, encodeId=1efd110004067, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218184, encodeId=49dd1218184bc, content=投个案的时候需要上传Clinical Practice Points,有没有大佬知道这是什么意思呀?需要怎么准备呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca065431027, createdName=ms4000001550793649, createdTime=Mon May 09 13:52:57 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100039, encodeId=3f001100039a3, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548146, encodeId=abba54814655, content=楼下说的确实太慢了,现在如何,中间没有催过吗? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a33e1700270, createdName=dapengshiwo, createdTime=Wed Oct 11 20:42:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547302, encodeId=34d754e30284, content=投稿两个月了,还是with editor 不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8031642220, createdName=黄倩倩, createdTime=Sun Sep 17 20:56:00 CST 2017, time=2017-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522551, encodeId=87205225517e, content=投稿两个月,状态还是“with editor”,这是什么意思?!肯本没送审,等着毕业呀,好歹给个消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f119101875, createdName=Blank, createdTime=Wed May 18 09:53:00 CST 2016, time=2016-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504526, encodeId=26575045264e, content=总体来说,形式是比较看好的,今年快到3分左右,比去年高了不少,明年应该能达到3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiming, createdTime=Wed Jul 30 12:55:00 CST 2014, time=2014-07-30, status=1, ipAttribution=)]
    2021-12-29 学医的彭于晏

    上传文章有什么要求?

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1100040, encodeId=1efd110004067, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218184, encodeId=49dd1218184bc, content=投个案的时候需要上传Clinical Practice Points,有没有大佬知道这是什么意思呀?需要怎么准备呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca065431027, createdName=ms4000001550793649, createdTime=Mon May 09 13:52:57 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100039, encodeId=3f001100039a3, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548146, encodeId=abba54814655, content=楼下说的确实太慢了,现在如何,中间没有催过吗? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a33e1700270, createdName=dapengshiwo, createdTime=Wed Oct 11 20:42:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547302, encodeId=34d754e30284, content=投稿两个月了,还是with editor 不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8031642220, createdName=黄倩倩, createdTime=Sun Sep 17 20:56:00 CST 2017, time=2017-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522551, encodeId=87205225517e, content=投稿两个月,状态还是“with editor”,这是什么意思?!肯本没送审,等着毕业呀,好歹给个消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f119101875, createdName=Blank, createdTime=Wed May 18 09:53:00 CST 2016, time=2016-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504526, encodeId=26575045264e, content=总体来说,形式是比较看好的,今年快到3分左右,比去年高了不少,明年应该能达到3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiming, createdTime=Wed Jul 30 12:55:00 CST 2014, time=2014-07-30, status=1, ipAttribution=)]
    2017-10-11 dapengshiwo

    楼下说的确实太慢了,现在如何,中间没有催过吗?

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1100040, encodeId=1efd110004067, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218184, encodeId=49dd1218184bc, content=投个案的时候需要上传Clinical Practice Points,有没有大佬知道这是什么意思呀?需要怎么准备呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca065431027, createdName=ms4000001550793649, createdTime=Mon May 09 13:52:57 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100039, encodeId=3f001100039a3, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548146, encodeId=abba54814655, content=楼下说的确实太慢了,现在如何,中间没有催过吗? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a33e1700270, createdName=dapengshiwo, createdTime=Wed Oct 11 20:42:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547302, encodeId=34d754e30284, content=投稿两个月了,还是with editor 不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8031642220, createdName=黄倩倩, createdTime=Sun Sep 17 20:56:00 CST 2017, time=2017-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522551, encodeId=87205225517e, content=投稿两个月,状态还是“with editor”,这是什么意思?!肯本没送审,等着毕业呀,好歹给个消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f119101875, createdName=Blank, createdTime=Wed May 18 09:53:00 CST 2016, time=2016-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504526, encodeId=26575045264e, content=总体来说,形式是比较看好的,今年快到3分左右,比去年高了不少,明年应该能达到3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiming, createdTime=Wed Jul 30 12:55:00 CST 2014, time=2014-07-30, status=1, ipAttribution=)]
    2017-09-17 黄倩倩

    投稿两个月了,还是with editor 不知道还要等多久

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1100040, encodeId=1efd110004067, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218184, encodeId=49dd1218184bc, content=投个案的时候需要上传Clinical Practice Points,有没有大佬知道这是什么意思呀?需要怎么准备呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca065431027, createdName=ms4000001550793649, createdTime=Mon May 09 13:52:57 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100039, encodeId=3f001100039a3, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548146, encodeId=abba54814655, content=楼下说的确实太慢了,现在如何,中间没有催过吗? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a33e1700270, createdName=dapengshiwo, createdTime=Wed Oct 11 20:42:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547302, encodeId=34d754e30284, content=投稿两个月了,还是with editor 不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8031642220, createdName=黄倩倩, createdTime=Sun Sep 17 20:56:00 CST 2017, time=2017-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522551, encodeId=87205225517e, content=投稿两个月,状态还是“with editor”,这是什么意思?!肯本没送审,等着毕业呀,好歹给个消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f119101875, createdName=Blank, createdTime=Wed May 18 09:53:00 CST 2016, time=2016-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504526, encodeId=26575045264e, content=总体来说,形式是比较看好的,今年快到3分左右,比去年高了不少,明年应该能达到3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiming, createdTime=Wed Jul 30 12:55:00 CST 2014, time=2014-07-30, status=1, ipAttribution=)]
    2016-05-18 Blank

    投稿两个月,状态还是“with editor”,这是什么意思?!肯本没送审,等着毕业呀,好歹给个消息

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1100040, encodeId=1efd110004067, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218184, encodeId=49dd1218184bc, content=投个案的时候需要上传Clinical Practice Points,有没有大佬知道这是什么意思呀?需要怎么准备呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca065431027, createdName=ms4000001550793649, createdTime=Mon May 09 13:52:57 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100039, encodeId=3f001100039a3, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548146, encodeId=abba54814655, content=楼下说的确实太慢了,现在如何,中间没有催过吗? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a33e1700270, createdName=dapengshiwo, createdTime=Wed Oct 11 20:42:00 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547302, encodeId=34d754e30284, content=投稿两个月了,还是with editor 不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8031642220, createdName=黄倩倩, createdTime=Sun Sep 17 20:56:00 CST 2017, time=2017-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522551, encodeId=87205225517e, content=投稿两个月,状态还是“with editor”,这是什么意思?!肯本没送审,等着毕业呀,好歹给个消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f119101875, createdName=Blank, createdTime=Wed May 18 09:53:00 CST 2016, time=2016-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504526, encodeId=26575045264e, content=总体来说,形式是比较看好的,今年快到3分左右,比去年高了不少,明年应该能达到3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiming, createdTime=Wed Jul 30 12:55:00 CST 2014, time=2014-07-30, status=1, ipAttribution=)]
    2014-07-30 qiming

    总体来说,形式是比较看好的,今年快到3分左右,比去年高了不少,明年应该能达到3分

    0

共10条页码: 1/1页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分